ResMed (RMD)
(Delayed Data from NYSE)
$197.04 USD
-11.30 (-5.42%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $197.20 +0.16 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Brokerage Reports
0 items in cart
ResMed Inc. [RMD]
Reports for Purchase
Showing records 441 - 460 ( 531 total )
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q4 FY2016 revenue ahead of expectations, target to $65, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q3 FY2016 EPS misses, technology acquisitions to help future margin, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Acquiring Brightree, SaaS provider, for $800 million - maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q2 FY2016 ahead of consensus - Air Solutions driving sustainable mask growth?
Provider: Feltl & Company
Analyst: HAYNOR B